AAAAAA
Results: 1-25/40
Authors:
Buchner, T
Hiddemann, W
Schoch, C
Haferlach, T
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Acute myeloid leukaemia (AML): treatment of the older patient, BEST P R C, 14(1), 2001, pp. 139-151
In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye
Authors:
Babiole, M
Wilhelm, F
Schoch, C
Citation: M. Babiole et al., In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye, J OCUL PH T, 17(2), 2001, pp. 159-172
Authors:
Pabst, T
Mueller, BU
Harakawa, N
Schoch, C
Haferlach, T
Behre, G
Hiddemann, W
Zhang, DE
Tenen, DG
Citation: T. Pabst et al., AML1-ETO downregulates the granulocytic differentiation factor C/EBP alphain t(8;21) myeloid leukemia, NAT MED, 7(4), 2001, pp. 444-451
Authors:
Nickenig, C
Lang, NK
Schoch, C
Hiddemann, W
Haferlach, T
Citation: C. Nickenig et al., New insights into the biology of multiple myeloma using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level, ANN HEMATOL, 80(11), 2001, pp. 662-668
Authors:
Jahns-Streubel, G
Braess, J
Schoch, C
Fonatsch, C
Haase, D
Binder, C
Wormann, B
Buchner, T
Hiddemann, W
Citation: G. Jahns-streubel et al., Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF, LEUKEMIA, 15(3), 2001, pp. 377-384
Authors:
Wuchter, C
Ratei, R
Spahn, G
Schoch, C
Harbott, J
Schnittger, S
Haferlach, T
Creutzig, U
Sperling, C
Karawajew, L
Ludwig, WD
Citation: C. Wuchter et al., Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping, HAEMATOLOG, 86(2), 2001, pp. 154-161
Authors:
Buchner, T
Hiddemann, W
Berdel, W
Wormann, B
Loffler, H
Schoch, C
Haferlach, T
Ludwig, WD
Maschmeyer, G
Staib, P
Andreesen, R
Balleisen, L
Haase, D
Eimermacher, H
Aul, C
Rasche, H
Uhlig, J
Gruneisen, A
Reis, HE
Hartlapp, J
Hirschmann, WD
Weh, HJ
Pielken, HJ
Gassmann, W
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Remission induction therapy: the more intensive the better?, CANC CHEMOT, 48, 2001, pp. S41-S44
Authors:
Mahlknecht, U
Schnittger, S
Landgraf, F
Schoch, C
Ottmann, OG
Hiddemann, W
Hoelzer, D
Citation: U. Mahlknecht et al., Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosomep11.23 by in situ hybridization, CYTOG C GEN, 93(1-2), 2001, pp. 135-136
Authors:
Schoch, C
Bursch, S
Kern, W
Schnittger, S
Hiddemann, W
Haferlach, T
Citation: C. Schoch et al., Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemia, CANC GENET, 127(1), 2001, pp. 85-88
Authors:
Yu, DY
Su, EN
Cringle, SJ
Schoch, C
Percicot, CP
Lambrou, GN
Citation: Dy. Yu et al., Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles, INV OPHTH V, 42(7), 2001, pp. 1499-1504
Authors:
Braess, J
Jahns-Streubel, G
Schoch, C
Haase, D
Haferlach, T
Fiegl, M
Voss, S
Kern, W
Schleyer, E
Hiddemann, W
Citation: J. Braess et al., Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroupsin acute myeloid leukaemia, BR J HAEM, 113(4), 2001, pp. 975-982
Authors:
van der Velden, VHJ
Schoch, C
Langerak, AW
Schnittger, S
Hoogeveen, PG
van Dongen, JJM
Citation: Vhj. Van Der Velden et al., Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: Implications for detection of minimal residual disease, BR J HAEM, 113(4), 2001, pp. 1082-1083
Authors:
Bene, MC
Bernier, M
Casasnovas, RO
Castoldi, G
Doekharan, D
van der Holt, B
Knapp, W
Lemez, P
Ludwig, WD
Matutes, E
Orfao, A
Schoch, C
Sperling, C
van't Veer, MB
Citation: Mc. Bene et al., Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients, BR J HAEM, 113(3), 2001, pp. 737-745
Authors:
Schoch, C
Haferlach, T
Haase, D
Fonatsch, C
Loffler, H
Schlegelberger, B
Staib, P
Sauerland, MC
Heinecke, A
Buchner, T
Hiddemann, W
Citation: C. Schoch et al., Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients, BR J HAEM, 112(1), 2001, pp. 118-126
Authors:
Schoch, C
Kern, W
Krawitz, P
Dugas, M
Schnittger, S
Haferlach, T
Hiddemann, W
Citation: C. Schoch et al., Dependence of age-specific incidence of acute myeloid leukemia on karyotype, BLOOD, 98(12), 2001, pp. 3500-3500
Authors:
Dreyling, MH
Schrader, K
Muschinsky, V
Fonatsch, C
Schlegelberger, B
Haase, D
Schoch, C
Ludwig, WD
Hiddemann, W
Bohlander, SK
Citation: Mh. Dreyling et al., Molecular characterization of the translocation (10;11)(p13;q14): MLL and CALM are fused to AF10 in morphologically different subsets of acute leukemia, HEMAT BLOOD, 40, 2001, pp. 20-26
Authors:
Schnittger, S
Kinkelin, U
Schoch, C
Haase, D
Haferlach, T
Buchner, T
Wormann, B
Hiddemann, W
Griesinger, F
Citation: S. Schnittger et al., MLL-duplications are rare and associated with poor prognosis in acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 27-33
Authors:
Schnittger, S
Schoch, C
Griesinger, F
Buchner, T
Loffler, H
Haferlach, T
Hiddemann, W
Citation: S. Schnittger et al., RT-PCR in diagnostics and monitoring of acute myeloid, HEMAT BLOOD, 40, 2001, pp. 44-48
Authors:
Horn, PA
Tesch, H
Staib, P
Schoch, C
Kube, D
Diehl, V
Voliotis, D
Citation: Pa. Horn et al., Significance of AC133 and CD34 expression on acute myeloid leukemia cells, HEMAT BLOOD, 40, 2001, pp. 160-165
Authors:
Schoch, C
Klaus, M
Bursch, S
Buchner, T
Loffler, H
Haferlach, T
Hiddemann, W
Citation: C. Schoch et al., Although patients with AML and complex aberrant karyotype can be subdivided into different subtypes by cytogenetics, prognosis is equally poor, HEMAT BLOOD, 40, 2001, pp. 172-175
Authors:
Staib, P
Schinkothe, T
Wiedenmann, S
Dimski, T
Schoch, C
Voliotis, D
Horn, PA
Tesch, H
Lathan, B
Diehl, V
Citation: P. Staib et al., Prognostic relevance of in-vitro drug sensitivity testing in adult AML, HEMAT BLOOD, 40, 2001, pp. 251-256
Authors:
Kern, W
Schoch, C
Haferlach, T
Braess, J
Unterhalt, M
Wormann, B
Buchner, T
Hiddemann, W
Citation: W. Kern et al., Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: Significance of cytogenetic abnormalities, HEMAT BLOOD, 40, 2001, pp. 330-338
Authors:
Buchner, T
Hiddemann, W
Schoch, C
Haferlach, T
Eimermacher, H
Staib, P
Balleisen, L
Reis, HE
Pielken, HJ
Reichle, A
Schmoll, HJ
Griesinger, F
Gruneisen, A
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Treatment of older patients with acute myeloid leukemia (AML), HEMAT BLOOD, 40, 2001, pp. 611-620
Authors:
Schuldes, H
Dolderer, JH
Schoch, C
Bickeboller, R
Woodcock, BG
Citation: H. Schuldes et al., Cytostatic sensitivity and MDR in bladder carcinoma cells: implications for tumor therapy, INT J CL PH, 38(4), 2000, pp. 204-208
Authors:
Buchner, T
Hiddemann, W
Wormann, B
Loffler, H
Ludwig, WD
Schoch, C
Haferlach, T
Maschmeyer, G
Staib, P
Aul, C
Heyll, A
Gruneisen, A
Rasche, H
Eimermacher, H
Balleisen, L
Pielken, HJ
Reis, HE
Griesinger, F
Reichle, A
Sauerland, MC
Heinecke, A
Citation: T. Buchner et al., Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?, INT J HEMAT, 72(3), 2000, pp. 285-289